Actively Recruiting
Pilot Study of Intensive Cancer Screening Using FDG PETCT After First Cryptogenic Stroke
Led by Ottawa Hospital Research Institute · Updated on 2025-07-31
45
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating whether using a special imaging test called FDG PETCT along with usual cancer screening can detect hidden occult cancers more effectively in patients who have had a first unexplained ischemic stroke. This pilot trial aims to see if a larger study is possible and to compare cancer detection rates between the new screening method and standard care. The study is led by the Ottawa Hospital Research Institute and focuses on adults with cryptogenic stroke.
CONDITIONS
Brief Title
Intensive Cancer Screening After Cryptogenic Stroke
Research Team
D
Dariush Dowlatshahi, MD PhD
D
Deborah Siegal, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
